These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22035433)

  • 61. Etanercept in the treatment of adult patients with Still's disease.
    Husni ME; Maier AL; Mease PJ; Overman SS; Fraser P; Gravallese EM; Weinblatt ME
    Arthritis Rheum; 2002 May; 46(5):1171-6. PubMed ID: 12115220
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
    Kishida D; Okuda Y; Onishi M; Takebayashi M; Matoba K; Jouyama K; Yamada A; Sawada N; Mokuda S; Takasugi K
    Mod Rheumatol; 2011 Apr; 21(2):215-8. PubMed ID: 20931272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
    Wendling D; Dernis E; Prati C; Frisch E; Delbosc B
    J Rheumatol; 2011 Oct; 38(10):2284. PubMed ID: 21965707
    [No Abstract]   [Full Text] [Related]  

  • 64. Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease.
    Fortna RR; Gudjonsson JE; Seidel G; Dicostanzo D; Jacobson M; Kopelman M; Patel RM
    J Cutan Pathol; 2010 Sep; 37(9):932-7. PubMed ID: 20546088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting interleukin-6 in rheumatoid arthritis.
    Md Yusof MY; Emery P
    Drugs; 2013 Mar; 73(4):341-56. PubMed ID: 23456676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tocilizumab in pediatric rheumatology: the clinical experience.
    Gurion R; Singer NG
    Curr Rheumatol Rep; 2013 Jul; 15(7):338. PubMed ID: 23715975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hair-cycle changes in two patients taking tocilizumab.
    Vidon C; Bossert M; Lohse-Walliser A; Godfrin-Valnet M; Balblanc JC; Wendling D
    Joint Bone Spine; 2014 Jan; 81(1):100-1. PubMed ID: 23953226
    [No Abstract]   [Full Text] [Related]  

  • 68. Guidance on using tocilizumab for juvenile idiopathic arthritis.
    Yokota S; Imagawa T; Takei S; Murata T; Tomiita M; Itoh Y; Fujikawa S; Mori M
    Mod Rheumatol; 2011 Dec; 21(6):563-71. PubMed ID: 21597951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis].
    Popkova TV; Novikova DS; Nasonov EL
    Ter Arkh; 2016; 88(5):93-101. PubMed ID: 27458623
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sarcoidosis induced by tocilizumab: a paradoxical event?
    Nutz A; Pernet C; Combe B; Cohen JD
    J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
    [No Abstract]   [Full Text] [Related]  

  • 71. Sarilumab (Kevzara) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
    [No Abstract]   [Full Text] [Related]  

  • 72. The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
    Chighizola CB; Ong VH; Meroni PL
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):401-423. PubMed ID: 27515671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polyarticular late infection of total joint arthroplasties in a patient with rheumatoid arthritis treated with anti-interleukin-6 therapy.
    Wakabayashi H; Takigawa S; Hasegawa M; Kakimoto T; Yoshida K; Sudo A
    Rheumatology (Oxford); 2014 Jun; 53(6):1150-1. PubMed ID: 24273024
    [No Abstract]   [Full Text] [Related]  

  • 74. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience.
    De Vita S; Ferraccioli GF; Di Poi E; Bartoli E; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S85-92. PubMed ID: 8828953
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
    Zuelgaray E; Domont F; Peiffer-Smadja N; Saadoun D; Cacoub P
    Ann Intern Med; 2017 Jul; 167(2):141-142. PubMed ID: 28531906
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.
    Kawada J; Kitagawa Y; Iwata N; Ito Y
    Mod Rheumatol; 2013 Sep; 23(5):972-6. PubMed ID: 23070362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Rheumatoid Arthritis - New Treatment Options].
    Fiehn C
    Dtsch Med Wochenschr; 2017 Dec; 142(24):1844-1848. PubMed ID: 29207429
    [No Abstract]   [Full Text] [Related]  

  • 78. Tocilizumab for the treatment of juvenile idiopathic arthritis.
    Decelle K; Horton ER
    Ann Pharmacother; 2012 Jun; 46(6):822-9. PubMed ID: 22589451
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
    Wang J; Bansal AT; Martin M; Germer S; Benayed R; Essioux L; Lee JS; Begovich A; Hemmings A; Kenwright A; Taylor KE; Upmanyu R; Cutler P; Harari O; Marchini J; Criswell LA; Platt A
    Pharmacogenomics J; 2013 Jun; 13(3):235-41. PubMed ID: 22491018
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [IL-6 blockade therapy for inflammatory diseases: current perspectives and future directions].
    Tanaka T
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(6):433-42. PubMed ID: 27118330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.